rapamycin fed late life extends lifespan genetically heterogeneous mice
inhibition tor signalling pathway genetic pharmacological intervention extends lifespan invertebrates including yeast nematodes fruitflies- however whether inhibition mtor signalling can extend lifespan mammalian species unknown report rapamycin inhibitor mtor pathway extends median maximal lifespan male female mice fed beginning days age basis age % mortality rapamycin led increase % females % males effect seen three independent test sites genetically heterogeneous mice chosen avoid genotype-specific effects disease susceptibility disease patterns rapamycin-treated mice differ control mice separate study rapamycin fed mice beginning days age also increased survival males females based interim analysis conducted near median survival point rapamycin may extend lifespan postponing death cancer retarding mechanisms ageing knowledge first results demonstrate role mtor signalling regulation mammalian lifespan well pharmacological extension lifespan genders findings implications development interventions targeting mtor treatment prevention age-related diseases
